SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DR. BOND who wrote (2700)11/20/1997 12:02:00 PM
From: Sonki  Read Replies (1) of 23519
 
VIVUS Receives Compliance Notification From the FDA

MENLO PARK, Calif.--(BW HealthWire)--Nov. 20, 1997--VIVUS, Inc. (NASDAQ:VVUS - news) today announced that it was notified by the
U.S. Food and Drug Administration (FDA) that its original manufacturing facility is in compliance with the Agency's current Good Manufacturing
Practice (cGMP) requirements. This notification comes after a recent re-inspection of the VIVUS manufacturing facility in Lakewood, New Jersey.
VIVUS is currently expanding its production capacity by building out an additional 90,000 square-foot facility at the same business park in New
Jersey.

Founded in 1991, VIVUS, Inc. is a leader in the development of advanced therapeutic systems for the treatment of erectile dysfunction, commonly
referred to as impotence. VIVUS has pioneered a novel therapy for erectile dysfunction known as the transurethral system for erection. This therapy
consists of a proprietary, non-invasive drug delivery system that delivers pharmacologic agents via the urethra.

Note to Editors and Investors: Additional written materials, recent releases and Company information are available through a variety of sources,
including the VIVUS home page (www.vivus.com) and the VIVUS Fax-On-Demand Service (888/329-5719).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News